Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Methylation analyses using home-based self-sampling in women with and without gynecological disease

Official title: Methylation Analyses for Gynaecological Research Through Home-based Self-sampling

Run by Universiteit Antwerpen · NCT07902388 · Data updated 2026-11-12

This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment512 (estimated)
SponsorUniversiteit Antwerpen
Academic / other
Locations1 site (Edegem, Antwerp)
StatusRecruiting
StartedApril 13, 2026
Main results expectedDecember 31, 2032
Study endsDecember 31, 2032
Registry record updatedNovember 6, 2026
Trial IDNCT07902388 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women and people with female genital organs aged 18 or older, Belgian nationality, who can provide informed consent and perform self-sampling.

Probably not a fit

Individuals who have a history of gynecological cancer, are pregnant or postpartum within 6 months, or cannot perform self-sampling may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The MARGOT study collects self-sampled first-void urine and vaginal material from adults to compare biomarker patterns with samples from individuals diagnosed with gynecological (pre-)cancers. Cancer-free controls are recruited through social media, volunteer databases, and healthcare posters, and may collect samples at home or at the study center. A questionnaire gathers information on risk factors and experiences with self-sampling while samples are analyzed using the Colli-Pee device with UCM and Evalyn Brush. The study aims to better understand differences in biological markers between these groups and to validate reference populations for future biomarker research. This is an interventional study with self-sampling as the core procedure, conducted at the University of Antwerp and affiliated centers.

Why it matters

Potential benefit: If successful, participants could contribute to improved screening methods for gynecological cancers based on self-collected samples.

How similar studies have gone: Previous biomarker and methylation analyses using self-samples have shown promise, but this exact home-based self-sampling approach combines novel elements and reference controls.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals having female genital organs, regardless of their gender identity.
* Participant is 18 years or older at the time of signing the informed consent form.
* Participant must be able to understand the (Dutch) information consent form and what the study is about.
* Participant must be able to provide written informed consent and take urine- and vaginal self-samples.
* Individual has a Belgian nationality.

Exclusion Criteria:

* Individuals that underwent hysterectomy or ovariectomy.
* Pregnant individuals or 6 months post-partum.
* (History of) (pre)cancer, or an ongoing diagnostic work-up or treatment for oncological concerns.
* Unable to give informed consent or to take urine- or vaginal self-samples.
* Participation in another interventional study. However, participation in another low-interventional or observational study is allowed.
* Individuals who have (a history) of postmenopausal bleeding.

Where it's running

  • University of Antwerp, Center for the Evaluation of Vaccination, Vaccinopolis
    Edegem, Antwerp, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.